Results 11 to 20 of about 75,592 (343)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency

open access: yesFrontiers in Endocrinology, 2019
The deficiency of 21-hydroxylase due to CYP21A2 pathogenic variants is a rather frequent disease with serious consequences, going from a real mortality risk to infertility and to milder symptoms, nevertheless important for affecting the patients' self ...
Duarte Pignatelli   +10 more
doaj   +2 more sources

Prednisolone impairs trabecular bone score changes in adolescents with 21-hydroxylase deficiency [PDF]

open access: yesClinical and Experimental Pediatrics
Background Individuals with 21-hydroxylase deficiency (21OHD) require lifelong glucocorticoid (GC) therapy, which increases their risk of fragility fractures.
Pattara Wiromrat   +5 more
doaj   +2 more sources

Clinical and molecular characteristics of simple virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: insight from a tertiary pediatric center in Vietnam [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism
Purpose Simple virilizing congenital adrenal hyperplasia (SV-CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal recessive disease caused by pathogenic variants of the CYP21A2 gene.
Khanh Ngoc Nguyen   +8 more
doaj   +2 more sources

Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)

open access: yesClinical Pediatric Endocrinology, 2022
. Congenital adrenal hyperplasia is a category of disorders characterized by impaired adrenocortical steroidogenesis. The most frequent disorder of congenital adrenal hyperplasia is 21-hydroxylase deficiency, which is caused by pathogenic variants of ...
T. Ishii   +14 more
semanticscholar   +1 more source

Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe

open access: yesEuropean Journal of Endocrinology, 2022
Objective To assess the current medical practice in Europe regarding prenatal dexamethasone (Pdex) treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
H. Nowotny   +41 more
semanticscholar   +1 more source

Mass spectrometry: an essential tool to be used in discrimination between causes of congenital adrenal hyperplasia, and its benefits versus radioimmunoassay

open access: yesBeni-Suef University Journal of Basic and Applied Sciences, 2021
Background Measurement of multiple steroids, 17 hydroxyprogesterone, 11 deoxycortisol, and 21 deoxycortisol, is required to discriminate between congenital adrenal hyperplasia due to 21 hydroxylase deficiency and that due to 11 beta hydroxylase ...
Heba Asfour   +6 more
doaj   +1 more source

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

open access: yesFrontiers in Endocrinology, 2022
Substantial research has been performed during the last decades on the clinical and genetic variability of congenital adrenal hyperplasia (CAH) and its most common form, 21-hydroxylase deficiency (21OHD).
M. Kocova, P. Concolino, H. Falhammar
semanticscholar   +1 more source

Case Report: Infant With Congenital Adrenal Hyperplasia and 47,XXY

open access: yesFrontiers in Genetics, 2022
Congenital adrenal hyperplasia is a group of autosomal recessive disorders in which enzymes in the cortisol biosynthesis pathways are disrupted by gene mutations. The most common form of congenital adrenal hyperplasia, caused by 21-hydroxylase deficiency,
Sophia Q. Song   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy